Gufic Biosciences Limited (GUFICBIO.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 27.47B |
| Enterprise Value | 30.76B |
| P/E Ratio | 66.53 |
| PEG Ratio | 3.57 |
| Price/Sales Ratio | 4.98 |
| Price/Book Ratio | 7.36 |
| Enterprise/Revenue | 4.98 |
| Enterprise/EBITDA | 29.49 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 9.44B |
| Revenue/Share | 97.61 |
| Gross Profit | 3.4B |
| EBITDA | 1.54B |
| Net Income | 642.15M |
| Diluted EPS | 6.4 |
Balance Sheet
| Total Cash | 621.86M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 66.16 |
Price History
| 52-Week Change | 47.24 |
| 52-Week High | 493.95 |
| 52-Week Low | 268 |
| Moving Average 50 Days | 422.98 |
| Moving Average 200 Days | 356.85 |
Statistics
| Average Volume | 116,449 |
| Shares Outstanding | 100.28M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 0.02 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
